Delivery Order SPE2DB22D1017-SPE2DB24FF3WX
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $3,451.95 by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $15,047.26 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $3,139.00 by the Defense Logistics Agency (DLA). The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a completion date of January 26, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a potential value of $4,108.03. The contract has a completion date of March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,131.70 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide "COSENTYX SNRDY 300MG DOSE-2PENML" pharmaceutical supplies. This contract has a completion date of January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,822.63 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract with DLA worth up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a potential value of $8,675.27 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order is issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $5,079.88 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of COSENTYX 300 MG DOSE-2 SYRINGE/ML, a specialty pharmaceutical product, with a completion date of February 2, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, delivering pharmaceuticals and medical supplies to military treatment...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $17,701.03 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Cencora, Inc., was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, with a potential value of $3,912.94 and a period of performance through March 8, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3WXDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. The contract has a potential value of $4,734.61 and a completion date of March 8, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 3/7/24 |